Upload
Featured Recent Articles Topics Upload Login Sign Up

Search Results for 'ftc hiv'

ftc hiv published presentations and documents on DocSlides.

Comparison of NNRTI vs NNRTI
Comparison of NNRTI vs NNRTI
by lindy-dunigan
ENCORE. EFV vs RPV. ECHO-THRIVE. STAR. EFV vs ETR...
“On Demand” Oral PrEP: Lessons Learned from Macaque Models
“On Demand” Oral PrEP: Lessons Learned from Macaque Models
by giovanna-bartolotta
“On Demand” Oral PrEP: Lessons Learned from M...
Gilead Sciences, Inc., Foster City, CA, USA
Gilead Sciences, Inc., Foster City, CA, USA
by phoebe-click
Gilead Sciences, Inc., Foster City, CA, USA FTC/T...
Comparison of INSTI vs EFV
Comparison of INSTI vs EFV
by mediumgeneral
STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...
Comparison of RTV vs Cobi
Comparison of RTV vs Cobi
by studmonkeybikers
GS-US-216-0114. . Gallant JE. JID 2013;208:32-9...
Generic tenofovir disoproxil
Generic tenofovir disoproxil
by SunkissedBabe
fumarate and . emtricitabine. tablets obtained fr...
GS-US-380-1878 GS-US-380-1844
GS-US-380-1878 GS-US-380-1844
by phoebe
GS-US-380-1961. . Switch to BIC/FTC/TAF. Design...
Switching to TAF from TDF, each with RPV and FTC
Switching to TAF from TDF, each with RPV and FTC
by julia
Study GS-366-1216. Switch from TDF to TAF, each wi...
Jeanne Marrazzo, MD, MPH
Jeanne Marrazzo, MD, MPH
by rose
Professor of Medicine. University of Washington. S...
HIV 2020: Time for change
HIV 2020: Time for change
by garcia
Dr. Kay Mahomed. Netcare. Garden City Clinic. Ma...
Cases from the Clinic(ians): Case-based Panel Discussion
Cases from the Clinic(ians): Case-based Panel Discussion
by tripp
Associate Dean for Global Health. University of Al...
CROI 2015: HIV Prevention Updates
CROI 2015: HIV Prevention Updates
by pamella-moone
Ruanne V Barnabas, . MBChB. . Dphil. Global Heal...
ID Week 2016: HIV Update
ID Week 2016: HIV Update
by min-jolicoeur
Robert Harrington, M.D.. ID Week 2016: HIV Update...
Overview of HIV Epidemiology and Prevention Sciences for ke
Overview of HIV Epidemiology and Prevention Sciences for ke
by alida-meadow
Stefan Baral, MD MPH FRCPC. Center for Public Hea...
Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan
Second-Generation HIV-1 Maturation Inhibitor BMS-955176: Antiviral Activity and Safety with Atazan
by sherrill-nordquist
± . Ritonavir. Carey Hwang. ,. 1. Dirk Schürma...
The Future of HIV Treatment
The Future of HIV Treatment
by myesha-ticknor
Greg Perry. Melbourne – International AIDS Conf...
Essentials for Optimal Care of HIV Patients
Essentials for Optimal Care of HIV Patients
by marina-yarberry
Evidence-Based Approaches. Simply Speaking. ®. ...
Treating HIV Infection: HIV/AIDS Treatment
Treating HIV Infection: HIV/AIDS Treatment
by celsa-spraggs
A Dynamic Field. SINGLE Study. Phase 3, Open-Labe...
HIV PREVENTION SAMU SUMMARY
HIV PREVENTION SAMU SUMMARY
by FluffyFace
2018. Objectives . To describe the current situati...
Optimizing HIV treatment
Optimizing HIV treatment
by anderson
Professor Francois Venter. Ezintsha, University of...
Susan P. Buchbinder, MD Director, Bridge HIV
Susan P. Buchbinder, MD Director, Bridge HIV
by harmony
San . Francisco Department . of Public Health. Cli...
Innovative Strategies for the Management
Innovative Strategies for the Management
by karlyn-bohler
of HIV Infection. Dual therapies without NRTIs. J...
The Bangkok Tenofovir Study
The Bangkok Tenofovir Study
by marina-yarberry
An HIV pre-exposure prophylaxis trial in Thailand...
Hepatitis B Case Studies
Hepatitis B Case Studies
by yoshiko-marsland
Nina Kim, MD MSc. Associate Professor of Medicine...
ART as prevention: PEP &
ART as prevention: PEP &
by phoebe-click
PrEP. Dr. Laura Waters. HIV/GU Medicine. Brighto...
Comparison of INSTI vs INSTI
Comparison of INSTI vs INSTI
by pamella-moone
QDMRK. SPRING-2. ONCEMRK. ONCEMRK. Design. Object...
ART Initiation in Resource-Limited Settings
ART Initiation in Resource-Limited Settings
by lois-ondreau
Susan M. Graham . Assistant Professor, Medicine a...
Hepatitis B Case Studies
Hepatitis B Case Studies
by alida-meadow
Nina Kim, MD MSc. Associate Professor of Medicine...
The Evidence
The Evidence
by danika-pritchard
– . PrEP. Effectiveness. Module . 1(b). The Ev...
PrEP Training for
PrEP Training for
by tatyana-admore
Providers in Clinical Settings. 2. Welcome!. Plea...
ART for Prevention… What Happens Next?
ART for Prevention… What Happens Next?
by briana-ranney
Myron S. Cohen, MD. Yeargan-Bate Eminent Professo...
Characteristics and Oral
Characteristics and Oral
by lois-ondreau
PrEP. Adherence in the TDF2 Open-Label Extension...
ADOLESCENT PrEP STUDIES
ADOLESCENT PrEP STUDIES
by min-jolicoeur
. . Shorai. . Mukaka. , . MBchB. ...
The Role of Pre-Exposure Prophylaxis (
The Role of Pre-Exposure Prophylaxis (
by tatyana-admore
PrEP. ) for the Prevention of HIV. Sarah . Kemink...
Highlights for clinical
Highlights for clinical
by pasty-toler
. practice. HIV. International Congress of Drug ...
Use the Web Browser on Your Mobile Device to Participate in Polling*
Use the Web Browser on Your Mobile Device to Participate in Polling*
by phoebe-click
Go to: pollev.com/CCO2. or scan the QR code below...
Donna E. Sweet, MD, AAHIVS, MACP
Donna E. Sweet, MD, AAHIVS, MACP
by pasty-toler
Professor of Medicine. The University of Kansas S...
Module 1: INTRODUCTION TO ORAL
Module 1: INTRODUCTION TO ORAL
by pamella-moone
PrEP. Version. : December . 2018. Outline of tra...
Comparison of PI vs PI ATV vs ATV/r BMS 089
Comparison of PI vs PI ATV vs ATV/r BMS 089
by phoebe-click
LPV/r mono vs LPV/r ZDV/3TC MONARK. LPV/r QD v...
2013 Antimicrobial Update
2013 Antimicrobial Update
by marina-yarberry
Oklahoma ACP Chapter . October 18, 2013. Michelle...